Skip to content

Safety and efficacy of minimally invasive glaucoma surgery in the treatment of glaucoma

Safety and efficacy of minimally invasive glaucoma surgery in the treatment of glaucoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081843
Enrollment
Unknown
Registered
2024-03-13
Start date
2023-04-01
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

MIGS group:None

Sponsors

The Third Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: a. Age: =18 years old; b. Patients with MIGS for glaucoma, including but not limited to primary open-angle glaucoma, primary angleclosure glaucoma, various childhood glaucoma, secondary glaucoma, and patients with intraocular pressure failure after anti-glaucoma surgery.

Exclusion criteria

Exclusion criteria: a. History of serious systemic diseases: diabetes mellitus, hypertension (systolic blood pressure = 160mmHg or diastolic blood pressure = 100mmHg), heart disease, kidney disease, rheumatic immune disease, digestive system disease, tumor, etc.; b. Complicated with other serious eye diseases, such as diabetic retinopathy, age-related macular degeneration, eye trauma, strabismus, nystagmus, severe dry eye, ptosis, etc

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;

Secondary

MeasureTime frame
Best corrected visual acuity;Visual field;Retinal nerve fiber layer thickness;

Countries

China

Contacts

Public ContactXie Lin

The Third Affiliated Hospital of Chongqing Medical University

xielin_66@163.com+86 139 8366 3778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026